Cleared Traditional

K123002 - VITAL SYNC SYSTEM

K123002 is an FDA 510(k) clearance for VITAL SYNC SYSTEM, manufactured by Covidien, Formerly Nellcor Puritan Bennett, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 153-day FDA review.

K123002 · Covidien, Formerly Nellcor Puritan Bennett, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2013
Decision
153d
Days
Class 2
Risk

K123002 is an FDA 510(k) clearance for the VITAL SYNC SYSTEM. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Covidien, Formerly Nellcor Puritan Bennett, Inc. (Boulder, US). The FDA issued a Cleared decision on February 27, 2013 after a review of 153 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Covidien, Formerly Nellcor Puritan Bennett, Inc. devices

FDA 510(k) Submission Details - K123002

510(k) Number K123002 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2012
Decision Date February 27, 2013
Days to Decision 153 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 125d · This submission: 153d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 295
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K123002.
WVSM (WIRLESS VITAL SIGNS MONITOR)
K130957 · Athena Gtx · Apr 2013
PATIENT MONITOR
K130056 · Ld Technology, LLC · Apr 2013
NUVON VITALS CHARTING SYSTEM
K130234 · Nuvon, Inc. · Mar 2013
MRI PATIENT MONITORING SYSTEM (MODEL 865214)
K124061 · Invivo Corporation · Feb 2013
COMEN MULTI-PARAMETER PATIENT MONITOR
K112877 · Goldway Us, Inc. · Nov 2012
AIRSTRIP REMOTE PATIENT MONITORING (RPM) REMOTE DATA VIEWING
K122133 · Airstrip Technologies, LP · Oct 2012